Page 4 - Burnet Institute

Addiction

Drug consumption room recommended for ACT

A study led by Burnet Senior Research Fellow, Amy Kirwan has recommended a drug consumption room (DCR) be introduced in the Australian Capital Territory (ACT) in a bid to counter significant and escalating drug-related harm ...

Diseases, Conditions, Syndromes

How COVID-19 is affecting global efforts to eliminate malaria

The epidemiology of COVID-19 is complicated. We've worked out the virus spreads through the air, so instead of wiping things down as was first recommended in 2020 we are now looking to masks and ventilation as key public ...

Diseases, Conditions, Syndromes

New insights into immunity to malaria in pregnancy

New Burnet Institute research has revealed the importance of specific proteins in the blood known as complement to clear infection and prevent malaria in pregnancy, a cause of severe disease and significant maternal, fetal, ...

Diseases, Conditions, Syndromes

Experts urge caution on Omicron variant

Allowing the omicron variant to run its course in the community in the expectation that it will prove to be less virulent than delta would be a serious mistake, Burnet Institute Deputy Director, Associate Professor David ...

Diseases, Conditions, Syndromes

Sustained investment is needed to eliminate hepatitis C by 2030

A new national report released today highlights a decline in hepatitis C testing and treatment uptake, putting Australia at risk of not achieving its target of eliminating hepatitis C as a public health threat by 2030.

Diseases, Conditions, Syndromes

New treatment pathways for hepatitis C

A newly published Burnet Institute study has demonstrated the feasibility and effectiveness of simplified clinical pathways for treatment of hepatitis C (HCV) in Myanmar.

page 4 from 5